tirzepatide protein intake optimization research on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Weight Loss Blog – Maryland

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

"It is kind of like bushes around your deck

4,5 However, newer therapies, including the glucagon-like peptide 1 receptor agonist (GLP-1 RA) semaglutide and the dual GLP-1 RA/gastric inhibitory polypeptide (GIP) agonist tirzepatide, have demonstrated substantial weight reduction in patients with obesity, with and without type 2 diabetes (T2D), in randomized clinical trials (RCTs)

Repeatedly using them together can also cause brain damage

6 Many of these effects occurred at doses that also caused maternal weight loss, which makes interpretation harder but doesnt remove the regulatory concern

In fact, it is considered both normal and healthy when experienced during an anxiety-inducing situation, such as speaking in front of a large crowd or attending an interview